Moreover, we found that EA treatment downregulated microglial polarization‐associated neuroinflammation by regulating the TGF‐β/Smad‐3 signaling pathway, highlighting a potential therapeutic mechanism of EA in stroke recovery. This evidence concerns the gene TGFB1 and stroke disorder.